

|
putting the focus on ADMET properties |
| CSBBB ... a new Log BB predictor |
| TM |
| ...a new leading-edge Blood-Brain Barrier partition predictor |
Excellent Accuracy by External Validation... |
|
External validation gave R2ExVal = 0.62 with MAE = 0.37 on a highly diverse set of of 74 drugs, which is the largest such dataset ever reported with this observed accuracy. The CSBBB QSAR cross-validated, neural net model was based on 103 compounds (Q210% = 0.76, MAE = 0.30) with the use of proprietary topological descriptors. |
| Continuous Processing.. Run upwards of 90,000 compounds per hour to screen any size HTS library |
|
Non-fragment Approach.. Nine non-fragment descriptors are applied to highly diverse compounds in the MW range from 101 to 1300 with a LogBB in range from -2 to 2. |
|
Import Results.. Directly to ChemFinder™/ISISBase™/MDL QSAR™ for visualization of compounds via CS-SDF output |
Please visit the information pages about our CSBBB predictor |

|
Seeing is Believing |
|
To register or login for a Free Trial of our property predictors |
| search | |
| links | |
| user login | |
| contact us | |
|
To contact us: |
![]() |
Phone: 978-501-0633 Fax: 781-275-5197 Email: sales@chemsilico.com |
Copyright © 2003 ChemSilico LLC All Rights Reserved Terms and Conditions of Use | Privacy Policy ChemSilico is a registered trademark of ChemSilico LLC, Tewksbury, MA 01876 |
| ChemFinder™, registered TM of Cambridgesoft. ISISBase™, MDL QSAR™, registered TMs of MDL Information Systems. |